Disputas: Walaa Abuelmagd
Ph.d.-kandidat Walaa Abuelmagd ved Farmasøytisk institutt, Det matematisk-naturvitenskapelige fakultet, vil forsvare avhandlingen "Management of Type 2 Diabetes in Non-Western Patient Groups. Results from Pakistani and Kurdish immigrant populations in Norway and from the native population in the United Arab Emirates" for graden Philosophiae Doctor.
Prøveforelesning - tid og sted
17.01.2020 10.15, Auditorium 1, Farmasibygningen
How does one ensure rigour in qualitative research?
Avhandlingen omhandler hvordan tre grupper ikke-vestlige pasienter med type 2 diabetes håndterer egen sykdom. Forskjellen mellom gruppene viser at språkkunnskaper, utdanningsnivå og andre kulturelle faktorer er avgjørende for hvor godt de klarer å håndtere sykdommen.
In this thesis, it has been shown that the management of Type 2 diabetes mellitus (T2DM) in the immigrant women in Norway and the native Emirati women in the United Arab Emirates was largely suboptimal in terms of lifestyle habits, blood glucose monitoring and medication adherence during Ramadan. Linguistic barriers, as observed in the Pakistanis, low level of education as observed in the Pakistanis and the Emiratis, made self-management difficult. Both patient groups reported modifications in medicine schedule for their fasting period in Ramadan. The third group, the Kurdish immigrant women and men in Norway, were well versed in comprehending the Norwegian language and were literate, and expressed that their management of T2DM was largely successful. They expressed how they had made an effort to have a healthy diet, had incorporated blood glucose monitoring into their daily routines, and to be adherent to their medication. The levels of physical activity were low in the three study populations.
The results help us understand that linguistic barriers, low level of education and other cultural factors that may decide on how certain patient groups should be followed up regarding their disease, medication treatment and other aspects of T2DM management.
For mer informasjon: Farmasøytisk institutt